Commercial-stage biopharma developing precision therapies for rare MC4R pathway diseases
Rhythm Pharmaceuticals is a Boston-based, commercial-stage biopharma focused on rare neuroendocrine and MC4R pathway diseases. Hiring is accelerating and skews senior and director-level, led by sales and field healthcare roles across the US, Europe and Canada, which points to commercial launch expansion over early research. A stack of Veeva RIM, Veeva QualityDocs and SAS alongside Snowflake and Power BI reflects regulated multi-country operations paired with a modern analytics layer.
Notable leadership hires: Medical Director, Head of Strategic Sourcing
Rhythm Pharmaceuticals is a public biopharmaceutical company founded in 2008 and headquartered in Boston, Massachusetts, with 201–500 employees. It develops and commercializes precision medicines for rare neuroendocrine diseases, with its lead asset marketed in North America, Europe and other regions. The pipeline includes clinical programs in rare MC4R pathway diseases, investigational MC4R agonists, and preclinical small molecules for congenital hyperinsulinism. The company serves healthcare providers, patients and families, supported by patient programs and medical education. It is hiring across the United States, Canada, the United Kingdom, Germany, the Netherlands, Switzerland and Peru.
Rhythm uses Veeva RIM and Veeva QualityDocs for regulatory and quality, SAS and Python for analysis, Snowflake and Power BI for data, Salesforce for CRM, plus Coupa, Concur, Ironclad, ADP and AWS, Azure and GCP.
Yes. Sales is the largest hiring area, followed by field healthcare roles, with an accelerating pace and a senior- and director-heavy mix including Medical Director and Head of Strategic Sourcing positions.
Rhythm hires in the United States, Canada, the United Kingdom, Germany, the Netherlands, Switzerland and Peru, consistent with commercializing its lead asset across North America and Europe.
Other companies in the same industry, closest in size
Rhythm Pharmaceuticals Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.